PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 16, 1984Science205 citations

Reaction of the Antitumor Antibiotic CC-1065 with DNA: Structure of a DNA Adduct with DNA Sequence Specificity

View Full Paper
LHLaurence H. HurleyVRVincent L. ReynoldsDSDavid H. Swenson

Key Points

Key points are not available for this paper at this time.

Abstract

Sequence-dependent variations in DNA revealed by x-ray crystallographic studies have suggested that certain DNA-reactive drugs may react preferentially with defined sequences in DNA. Drugs that wind around the helix and reside within one of the grooves of DNA have perhaps the greatest chance of recognizing sequence-dependent features of DNA. The antitumor antibiotic CC-1065 covalently binds through N-3 of adenine and resides within the minor groove of DNA. This drug overlaps with five base pairs for which a high sequence specificity exists.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hurley et al. (1984) studied this question.

synapsesocial.com/papers/6a8257c2e5668b15782a5b8fhttps://doi.org/10.1126/science.6494915
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival.1982 · 81 citations
  2. 2[57] Sequencing end-labeled DNA with base-specific chemical cleavages1980 · 14,699 citations
  3. 3Mechanism of interaction of CC-1065 (NSC 298223) with DNA.1982 · 103 citations
  4. 4CC-1065 (NSC-298223), a new antitumor antibiotic. Production, in vitro biological activity, microbiological assays and taxonomy of the producing microorganism.1978 · 275 citations
  5. 5The structure of CC-1065, a potent antitumor agent and its binding to DNA1981 · 152 citations